Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • (S)-(+)-Dimethindene maleate: Selective M2 Antagonist for...

    2026-03-10

    (S)-(+)-Dimethindene maleate: Selective M2 Antagonist for Pharmacological Profiling

    Executive Summary: (S)-(+)-Dimethindene maleate (SKU B6734) demonstrates high selectivity for the M2 muscarinic acetylcholine receptor, with substantially lower affinity for M1, M3, and M4 subtypes [APExBIO]. It also antagonizes histamine H1 receptors, supporting dual utility in autonomic and inflammatory pathway research [Gong et al., 2025]. The compound is highly water soluble (≥20.45 mg/mL) and is supplied at ≥98.00% purity. Its robust receptor selectivity and physicochemical profile enable reproducible results in cardiovascular, respiratory, and extracellular vesicle (EV) studies. Proper storage and handling are essential to maintain efficacy and minimize degradation.

    Biological Rationale

    The muscarinic acetylcholine receptor family modulates autonomic nervous system activity, affecting heart rate, airway tone, and secretory responses. M2 receptors are densely expressed in the cardiac atria and regulate vagal (parasympathetic) control of cardiac output. Selective antagonists like (S)-(+)-Dimethindene maleate are valuable for dissecting M2-specific signaling from overlapping M1, M3, and M4 pathways [Gong et al., 2025]. Histamine H1 receptors, implicated in allergic and inflammatory responses, are co-expressed with muscarinic receptors in airway and vascular tissues. Dual antagonism enables the study of receptor crosstalk and integrated autonomic/inflammatory responses. The compound’s high purity and solubility facilitate consistent dosing and experimental reproducibility.

    Mechanism of Action of (S)-(+)-Dimethindene maleate

    (S)-(+)-Dimethindene maleate acts as a competitive antagonist at the M2 muscarinic acetylcholine receptor, inhibiting acetylcholine-induced signaling cascades. This blockade diminishes parasympathetic tone, manifesting in increased heart rate and reduced bronchoconstriction in physiological models. The compound also antagonizes histamine H1 receptors, preventing histamine-mediated vasodilation, increased vascular permeability, and smooth muscle contraction. Its selectivity profile (Ki for M2 ≪ M1/M3/M4) is confirmed in radioligand binding and functional assays. The dual receptor blockade is particularly relevant for models that require uncoupling of muscarinic and histaminergic signaling pathways. The molecular formula is C20H24N2·C4H4O4, and the molecular weight is 408.5 g/mol [APExBIO].

    Evidence & Benchmarks

    • (S)-(+)-Dimethindene maleate exhibits ≥98.00% purity by HPLC under standard laboratory conditions (supplier certificate, APExBIO).
    • Demonstrates water solubility up to 20.45 mg/mL at room temperature (25°C, pH 7.4), supporting rapid dissolution in physiological buffers (APExBIO).
    • Selective antagonism of M2 muscarinic receptors confirmed by radioligand binding displacement assays; Ki for M2 is at least 10-fold lower than for M1 or M3 (see internal benchmark).
    • Provides robust inhibition of histamine H1 receptor-mediated signaling in primary cell and tissue models (Gong et al., 2025).
    • Utilized as a pharmacological tool to study autonomic regulation in cardiovascular and respiratory function assays (internal protocol extension).
    • Supports scalable EV production by enabling precise receptor modulation during cell expansion and differentiation workflows (Gong et al., 2025).

    Applications, Limits & Misconceptions

    (S)-(+)-Dimethindene maleate is primarily used in research settings to dissect muscarinic M2 and histamine H1 receptor signaling. Applications include:

    • Autonomic regulation research: Assessing parasympathetic modulation of cardiac and respiratory tissues.
    • Cardiovascular physiology studies: Elucidating M2-dependent heart rate and contractility changes.
    • Respiratory system function: Evaluating bronchomotor tone and airway responsiveness.
    • Receptor selectivity profiling: Benchmarking new ligands for muscarinic or histaminergic pathways.
    • Scalable regenerative medicine: Modulating receptor signaling during EV production from mesenchymal stem cells (Gong et al., 2025).

    For more hands-on protocols and troubleshooting, see the related article here, which details stepwise integration in EV workflows; this current article emphasizes selectivity and mechanistic profiling beyond the procedural scope.

    Common Pitfalls or Misconceptions

    • Not a pan-muscarinic antagonist: (S)-(+)-Dimethindene maleate does not equally inhibit M1, M3, or M4 subtypes; using it to block 'all muscarinic signaling' is inaccurate (see internal benchmark).
    • Not for diagnostic or therapeutic use: The compound is intended strictly for research; it lacks regulatory approval for human or veterinary medicine (APExBIO).
    • Stability concerns: Aqueous solutions must be used promptly; prolonged storage leads to degradation and reduced efficacy.
    • Not a general anti-inflammatory: While it blocks H1 receptors, it will not modulate all histamine or inflammatory responses.
    • Limited use in non-mammalian systems: Receptor homology and pharmacodynamics may differ in non-mammalian models.

    Workflow Integration & Parameters

    For experimental use, (S)-(+)-Dimethindene maleate is supplied as a solid and should be stored desiccated at room temperature (20–25°C). Dissolve in sterile water or buffer at concentrations up to 20.45 mg/mL. Solutions are not recommended for long-term storage; prepare fresh before use. For cell assays, titrate concentration based on receptor expression and desired blockade (typically 1–10 µM for in vitro, 0.1–1 mg/kg for in vivo). Validate selectivity in your system using appropriate controls. For EV biomanufacturing, add during critical phases of mesenchymal stem cell expansion to selectively modulate receptor signaling without off-target effects (Gong et al., 2025).

    For scenario-driven guidance on cytotoxicity and proliferation assays, see (S)-(+)-Dimethindene maleate: Reliable M2 Antagonist for ..., which focuses on workflow troubleshooting; this article provides updated selectivity and storage parameters.

    Conclusion & Outlook

    (S)-(+)-Dimethindene maleate, provided by APExBIO, is a rigorously characterized selective M2 muscarinic and H1 histamine receptor antagonist. Its high purity, solubility, and receptor selectivity underpin reproducible experimentation in autonomic, cardiovascular, respiratory, and regenerative medicine research. Proper handling and understanding of its selectivity are essential for experimental validity. Future advances may leverage this compound in scalable, automated EV biomanufacturing platforms, supporting translational and clinical studies (Gong et al., 2025).

    For comprehensive product data and ordering, see the (S)-(+)-Dimethindene maleate product page.
    For a methodological deep dive into selectivity-driven workflows, see (S)-(+)-Dimethindene maleate (SKU B6734): Reliable M2/H1 ...; this article updates protocol recommendations based on recent peer-reviewed findings.